SENNOSIDES A AND B

N/A

Manufactured by SDA Laboratories, Inc.

5,780 FDA adverse event reports analyzed

Last updated: 2026-04-15

About SENNOSIDES A AND B

SENNOSIDES A AND B is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by SDA Laboratories, Inc.. The most commonly reported adverse reactions for SENNOSIDES A AND B include PYREXIA, OFF LABEL USE, DYSPNOEA, CONSTIPATION, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SENNOSIDES A AND B.

Top Adverse Reactions

PYREXIA181 reports
OFF LABEL USE162 reports
DYSPNOEA141 reports
CONSTIPATION138 reports
FATIGUE127 reports
RASH121 reports
NAUSEA111 reports
DIARRHOEA107 reports
PAIN107 reports
HEADACHE106 reports
PNEUMONIA94 reports
MALAISE90 reports
BACK PAIN85 reports
DRUG INEFFECTIVE83 reports
ASTHMA81 reports
HYPERHIDROSIS78 reports
VOMITING78 reports
DECREASED APPETITE74 reports
FEBRILE NEUTROPENIA71 reports
HAEMOPTYSIS70 reports
INTENTIONAL PRODUCT MISUSE70 reports
INFUSION RELATED REACTION68 reports
CONDITION AGGRAVATED66 reports
FALL66 reports
ANXIETY64 reports
DEATH64 reports
HYPERTENSION63 reports
OVERDOSE63 reports
ERYTHEMA62 reports
VASCULITIS60 reports
COVID 1959 reports
DIZZINESS56 reports
THROMBOCYTOPENIA55 reports
EXPOSURE DURING PREGNANCY54 reports
ANAEMIA53 reports
PRODUCT USE ISSUE53 reports
PRODUCTIVE COUGH53 reports
ARTHRALGIA51 reports
PAIN IN EXTREMITY51 reports
PLEURAL EFFUSION51 reports
RENAL IMPAIRMENT51 reports
ACUTE KIDNEY INJURY50 reports
DRUG INTERACTION50 reports
PRURITUS49 reports
COUGH48 reports
DEHYDRATION48 reports
INSOMNIA48 reports
SEPSIS48 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE48 reports
WHEEZING48 reports
DRUG HYPERSENSITIVITY47 reports
HYPERSENSITIVITY47 reports
JOINT SWELLING47 reports
PNEUMONIA ASPIRATION47 reports
UPPER RESPIRATORY TRACT INFECTION47 reports
HALLUCINATION46 reports
ABDOMINAL PAIN45 reports
DRUG INTOLERANCE45 reports
HEPATIC ENZYME INCREASED45 reports
ABDOMINAL PAIN UPPER44 reports
FLUID RETENTION44 reports
FOETAL DEATH44 reports
MUSCULAR WEAKNESS44 reports
RASH ERYTHEMATOUS44 reports
SOMNOLENCE44 reports
FOOD ALLERGY43 reports
IMMUNODEFICIENCY43 reports
PRESCRIBED OVERDOSE43 reports
COGNITIVE DISORDER42 reports
PULMONARY FIBROSIS42 reports
OBSTRUCTIVE AIRWAYS DISORDER41 reports
PSORIASIS41 reports
RHEUMATOID ARTHRITIS41 reports
TOXICITY TO VARIOUS AGENTS41 reports
TREATMENT FAILURE41 reports
CONTRAINDICATED PRODUCT ADMINISTERED40 reports
INTERSTITIAL LUNG DISEASE40 reports
TEMPERATURE REGULATION DISORDER40 reports
ALOPECIA39 reports
DYSPHAGIA39 reports
CHEST PAIN38 reports
GASTROOESOPHAGEAL REFLUX DISEASE38 reports
LOWER RESPIRATORY TRACT INFECTION38 reports
NEUROLOGICAL SYMPTOM37 reports
PERIPHERAL SWELLING37 reports
PULMONARY ALVEOLAR HAEMORRHAGE37 reports
ASCITES35 reports
FEELING ABNORMAL35 reports
HYPOGLYCAEMIA35 reports
HYPOTHYROIDISM35 reports
LUNG DISORDER35 reports
MYOCARDIAL INFARCTION35 reports
NEURITIS35 reports
PLATELET COUNT DECREASED35 reports
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION35 reports
BLOOD GLUCOSE INCREASED34 reports
BURSITIS34 reports
HYPOTENSION34 reports
PULMONARY VASCULITIS34 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES33 reports

Report Outcomes

Out of 1,496 classified reports for SENNOSIDES A AND B:

Serious 92.8%Non-Serious 7.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female677 (51.2%)
Male643 (48.7%)
Unknown1 (0.1%)

Reports by Age

Age 7653 reports
Age 6551 reports
Age 8146 reports
Age 7445 reports
Age 7545 reports
Age 7240 reports
Age 6237 reports
Age 6437 reports
Age 6736 reports
Age 6936 reports
Age 7736 reports
Age 7031 reports
Age 7831 reports
Age 7329 reports
Age 6628 reports
Age 5825 reports
Age 6825 reports
Age 8025 reports
Age 6322 reports
Age 5921 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with SENNOSIDES A AND B?

This profile reflects 5,780 FDA FAERS reports that mention SENNOSIDES A AND B. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for SENNOSIDES A AND B?

Frequently reported terms in FAERS include PYREXIA, OFF LABEL USE, DYSPNOEA, CONSTIPATION, FATIGUE, RASH. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures SENNOSIDES A AND B?

Labeling and FAERS entries often list SDA Laboratories, Inc. in connection with SENNOSIDES A AND B. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.